Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis c
Symptom |infection
Sentences 498
PubMedID- 23087749 Since hbv and hcv share many risk factors and the same transmission routes, the high prevalence of occult hbv infection reported in patients with chronic hepatitis c, ranging from 6.7% to 91.1%, is not surprising (31, 32).
PubMedID- 26068212 Therefore, it is important to document hiv co-infections in regions with high hepatitis chronicity and hiv infection rates .
PubMedID- 23741761 Susceptibility factors (including excess hepatic iron, hfe mutations, alcohol consumption, infection with hepatitis c and/or human immunodeficiency viruses, oral estrogen use, smoking, and hepatotoxins e.g., hexachlorobenzene) play a significant role in development of clinical manifestations.
PubMedID- 24685721 Background & aims: production of interferon (ifn)-gamma by natural killer (nk) cells is attenuated during chronic infection with hepatitis c virus (hcv).
PubMedID- 23151512 Chronic infection with hepatitis c virus (hcv) is an important cause of end stage liver disease worldwide.
PubMedID- 21526182 Meanwhile, dqa1*0103 appears to provide protection against chronic active infection with hepatitis c virus .
PubMedID- 22419005 infection with the hepatitis c virus (hcv) affects nearly 200 million people in the world.
PubMedID- 26157746 Hepatocellular carcinoma (hcc) is a growing clinical problem, being the second leading cause of cancer deaths worldwide (globocan, http://globocan.iarc.fr) and one of the only increasing causes of cancer-related mortality in the u.s.1 in contrast to developing countries in the asia-pacific regions and sub-saharan africa, where hepatitis b virus (hbv) is the major risk factor for hcc, chronic infection with hepatitis c virus (hcv) has been a leading cause of hcc in developed countries2 and is the first indication for liver transplantation for patients with hcc in the u.s.3 worldwide, the world health organization (who) estimates that 3% of the world's population has been infected with hcv and that more than 170 million people are currently chronic carriers of hcv (who, www.who.int).
PubMedID- 21520209 We investigated the susceptibility of heparg hepatocytes to in vitro infection with serum-derived hepatitis c virus (hcv) particles (hcvsp) and the potential neutralizing activity of the e1e2-specific monoclonal antibody (mab) d32.10.
PubMedID- 23168863 infection with the hepatitis c virus as a risk factor of cardiovascular events in the early years after renal transplantation: a single center study from egypt.
PubMedID- 25646622 Along these lines, somewhat discouraging results have recently been reported from a phase i monotherapy trial of the hcv entry inhibitor itx-5061 given for up to 28 days in the setting of established chronic infection with the hepatitis c virus .
PubMedID- 24580042 The management of co-infection with hiv and hepatitis c virus (hcv) is complicated by viral and drug-drug interactions, treatment-related side effects, and the poor response to therapy of certain hcv genotypes.
PubMedID- 23327541 infection with hepatitis c virus (hcv) is associated with significant morbidity, mortality, and economic burden.
PubMedID- 22485129 About 90% of cases of liver cancer in japan are related to infection with hepatitis c or b virus .
PubMedID- 22291576 infection with hepatitis c virus was associated with 23,000 deaths from liver cancer (95% ci: 21,000–24,000).
PubMedID- 20085651 In addition, studies have implicated sr-bi as a key co-receptor mediating infection with the hepatitis c virus.
PubMedID- 26236109 infection with hepatitis c virus (hcv) is a global health problem and it is a leading cause for the development of liver fibrosis, cirrhosis, and hepatocellular carcinoma 1.
PubMedID- 21994696 Chronic infection with hepatitis c virus (hcv) is associated with significant liver disease and is therefore an important public health problem.
PubMedID- 22039483 For example, chronic infection with hepatitis c virus (hcv) results from reduction of the dimerization of mitochondrial antiviral signaling protein (mavs) by hcv nonstructural (ns) protein ns3/4a protease to levels that are too low to mount strong enough antiviral immune responses .
PubMedID- 20714004 infection with hepatitis c virus (hcv) is a worldwide health problem with more than 170 million infected individuals.
PubMedID- 25331321 Exclusion criteria: 1) co-infection with hepatitis c virus (hcv); 2) positive serum anti-hbc igm; 3) hbeag positive patients; 4) patients who had received prior antiviral therapy for hbv; 5) patients having stigmata of liver cell failure e.g., ascites, encephalopathy; 6) pregnancy or breast feeding; 7) patients with organ transplants; and 8) patients receiving steroids and/or immunosuppressive drugs.
PubMedID- 26374068 infection with hepatitis c, or if that fails, liver transplantation.
PubMedID- 24478542 Viral infection with hepatitis c virus (hcv) has a high propensity in becoming chronic and it is the major cause of hepatocellular carcinoma (hcc) worldwide.
PubMedID- 22585716 infection with hepatitis c virus (hcv) is a major risk factor for hepatocellular carcinoma (hcc) in india.
PubMedID- 22893870 The exclusion criteria included a co-infection with hepatitis c virus or human immunodeficiency virus, a history of taking other antiviral agents for chb, decompensated liver cirrhosis, hcc, and a concurrent use of immunosuppressive drugs or corticosteroids and underlying medical diseases accompanied by ascites such as congestive heart failure.
PubMedID- 22213804 infection with the hepatitis c virus is a major health burden worldwide (alter and seeff, 2000; lauer and walker, 2001).
PubMedID- 25170193 Chronic infection with hepatitis c virus (hcv) is a leading cause of liver-related morbidity and mortality worldwide and predisposes to liver fibrosis and end-stage liver complications.
PubMedID- 21914084 Chronic infection with hepatitis c virus (hcv) can induce insulin resistance (ir) in a genotype-dependent manner and contributes to steatosis, progression of fibrosis and resistance to interferon plus ribavirin therapy.
PubMedID- 25285757 Chronic infection with hepatitis c virus (hcv) may lead to b cell activation and transformation into non-hodgkin lymphoma (nhl).
PubMedID- 23534815 Objectives: infection with hepatitis c virus (hcv) is a major cause of chronic liver disease.
PubMedID- 25785448 Co-infection with hepatitis c virus (hcv) is common in patients with hiv-1 infection and hcv associated liver failure is a leading cause of death in hiv/hcv infected patients 1.
PubMedID- 25604355 Although chronic infection with hepatitis c virus (hcv) is the leading indication for liver transplantation in the united states, graft and patient survival rates are reduced because of hcv recurrence after transplant.
PubMedID- 24342744 Exclusion criteria included infection with hepatitis c or d viruses or human immunodeficiency virus.
PubMedID- 26225247 Chronic infection with hepatitis c virus (hcv) affects about 170 million people worldwide and is a major cause of liver complications.
PubMedID- 20002561 infection with the hepatitis c virus commonly occurs in patient groups who have difficulty accessing conventional medical care, reducing their chance of successful antiviral therapy.
PubMedID- 23710205 Recently, a retrospective study of 347 first lt recipients (donor or recipient cmv seropositive) transplanted for hcv was performed to evaluate the associations of cmv infection and disease with recurrent hepatitis c after lt. it was found that cmv infection was associated with increased risk of fibrosis stage ≧2 and inflammation grade ≧2 .
PubMedID- 21760886 Chronic infection with hepatitis c virus (hcv) is an important cause of liver cancer and end-stage liver disease in the united states and worldwide .
PubMedID- 25969625 At the present time, infection with hepatitis c virus (hcv) is a major health problem worldwide and it is the main cause of end stage liver diseases .
PubMedID- 25314116 Historically, clinical trials of regimens to treat chronic infection with hepatitis c virus (hcv) have used, as their primary efficacy endpoint, a sustained virological response (svr)-defined as hcv rna levels below a designated threshold of quantification-24 weeks after the end of treatment (svr24).
PubMedID- 22823899 Background: persistent infection with hepatitis c virus (hcv) is a leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
PubMedID- 26189518 Since the majority of hepatocellular carcinoma (hcc) arises from a background of chronic liver diseases caused by infection with hepatitis c virus (hcv) and hepatitis b virus (hbv), chemoprevention targeting patients at high risk of hcc is feasible.
PubMedID- 23409973 infection with hepatitis c virus (hcv) is a global health problem.
PubMedID- 22911841 Several factors have been identified as contributing to the excess risk of mortality observed in idus in the cart era including decreased access and adherence to cart , , and more comorbidities such as co-infection with hepatitis c , .
PubMedID- 22028994 Hiv infection is linked with hepatitis c infection, which is associated with insulin resistance and diabetes due to increased intrahepatic tumor necrosis factor (tnf-α) and hepatic steatosis.
PubMedID- 26069796 Four (4%) had co-infection with hepatitis c virus.
PubMedID- 23584069 These effects may be mediated by three general mechanisms:increasing hiv-related mortality directly (e.g., by exacerbating immunosuppression);enhancing the toxicity of art (e.g., by exacerbating the toxic effects of arvs on the liver i.e., hepatotoxicity); andincreasing mortality unrelated to hiv or art (e.g., by accelerating liver damage from concurrent infection with the hepatitis c virus hcv or increasing the likelihood of traumatic injury).
PubMedID- 22239506 Commonly known risk factors for infection with hepatitis c virus (hcv) include blood transfusion, injection drug use, intranasal cocaine use, and body tattoos.
PubMedID- 23626783 Differential expression of candidate virus receptors in human t lymphocytes prone or resistant to infection with patient-derived hepatitis c virus.
PubMedID- 26213549 In conclusion, hepatitis complicated with m. pneumoniae infection is not uncommon and generally has a relatively good prognosis since it showed no significant difference from m. pneumoniae infection as reported in the existing clinical researches.
PubMedID- 24734095 Older age, malnutrition and infection with hepatitis c virus and human immunodeficiency virus can also have some effects on reduction of the effectiveness of hbv vaccination (18-21).

Page: 1 2 3 4 5 6 7 8 9 10